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Abstract 
 
A subpopulation of GABAergic cells in cortical structures expresses CB1 cannabinoid 
receptors (CB1) on their axon terminals. In order to understand the function of these 
interneurons in information processing, it is necessary to uncover how they are embedded into 
neuronal circuits. Therefore, the proportion of GABAergic terminals expressing CB1 and the 
morphological and electrophysiological properties of CB1-immunoreactive interneurons 
should be revealed. We investigated the ratio and the origin of CB1-expressing inhibitory 
boutons in the CA3 region of the hippocampus. Using immunocytochemical techniques, we 
estimated that approximately 40 % of GABAergic axon terminals in different layers of CA3 
also expressed CB1. To identify the inhibitory cell types expressing CB1 in this region, we 
recorded and intracellularly-labeled interneurons in hippocampal slices. CB1-expressing 
interneurons showed distinct axonal arborization, and were classified as basket cells, mossy-
fiber-associated cells, dendritic-layer-innervating cells or perforant-path-associated cells. In 
each morphological category, a substantial variability in axonal projection was observed. In 
contrast to the diverse morphology, the active and passive membrane properties were found to 
be rather similar. Using paired recordings, we found that pyramidal cells displayed large and 
fast unitary postsynaptic currents in response to activating basket and mossy-fiber-associated 
cells, while they showed slower and smaller synaptic events in pairs originating from 
interneurons that innervate the dendritic layer, which may be due to dendritic filtering. In 
addition, CB1 activation significantly reduced the amplitude of the postsynaptic currents in 
each cell pair tested. Our data suggest that CB1-expressing interneurons with different axonal 
projections have comparable physiological characteristics, contributing to a similar proportion 
of GABAergic inputs along the somato-dendritic axis of CA3 pyramidal cells.  
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Introduction 
 
Cortical networks, including the hippocampus, comprise excitatory principal neurons 
and GABAergic inhibitory cells (Somogyi et al., 1985). Morphologically and functionally 
heterogeneous populations of inhibitory interneurons provide powerful control of principal 
cell function (Cobb et al., 1995; Miles et al., 1996) and are thus critically important for 
information processing (Buzsáki and Chrobak, 1995; Buzsaki and Moser, 2013). GABAergic 
cells in cortical circuits that express type 1 cannabinoid receptors (CB1) at their axon 
terminals form a unique group of local circuit neurons (Katona et al., 1999; Marsicano and 
Lutz, 1999). The inhibitory synaptic output of these interneurons can be effectively 
suppressed by activating CB1 (Hajos et al., 2000; Wilson and Nicoll, 2001) over a time period 
during which plastic changes at excitatory synapses may take place (Carlson et al., 2002). 
Thus, these interneurons are in a position to substantially affect learning processes at the 
cellular level (Puighermanal et al., 2009).  
In the hippocampus, the neuropeptide cholecystokinin (CCK), 5-HT3 serotonergic 
receptors (Morales and Bloom, 1997), nicotinic receptors containing alpha7 subunits 
(Freedman et al., 1993) and M3 muscarinic receptors (Cea-del Rio et al., 2010) have been 
consistently identified in CB1-expressing interneurons (Freund and Katona, 2007). In spite of 
the uniform expression of several receptor proteins and CCK, these interneurons show diverse 
morphological properties. In the CA1 region of the hippocampus, CB1 was shown to be 
present at boutons of inhibitory cells targeting different subcellular regions of pyramidal cells: 
basket cells that innervate the perisomatic region of the pyramidal cells, Schaffer collateral-
associated cells that project mainly to the stratum radiatum and also perforant-path-associated 
cells projecting to the stratum lacunosum-moleculare (Katona et al., 1999; Hajos et al., 2000; 
Cope et al., 2002; Klausberger et al., 2005). Thus, the outputs of CB1-expressing interneurons 
are distributed along the somato-dendritic axis of pyramidal cells in accordance with the main 
afferent pathways of the CA1 region. In contrast to the variability in axonal projection, CB1-
expressing interneurons in CA1 display rather similar properties in their synaptic output and 
firing behavior during distinct network activities in vivo (Klausberger et al., 2005; Daw et al., 
2009). 
 In the CA3 region, an area proposed to have distinct roles in memory function 
compared to CA1 (Buzsaki and Moser, 2013), CB1-expressing interneurons with diverse 
axonal arbors fire differently during theta and gamma oscillations (Lasztoczi et al., 2011). 
This finding suggests different roles for these CA3 interneuron types in hippocampal 
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operation. However, very little is known about the electrophysiological characteristics and 
features of the output synapses of CB1-expressing interneurons, which may influence their 
contribution to network activity.  
Here, we found that approximately 40% of GABAergic terminals expressed CB1 in the 
different layers of the CA3 hippocampal region. In spite of anatomical variability in the axon 
arbors, interneurons immunolabeled for CB1 were homogenous in their active and passive 
membrane characteristics, as well as in the properties of their output synapses. Our results 
indicate that different CB1-expressing interneurons contribute to the GABAergic innervation 
of distinct CA3 pyramidal cell surface domains to a similar extent. 
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Materials and Methods 
 
Animals and Slice Preparation. All experiments were carried out in accordance with the 
Hungarian Act of Animal Care and Experimentation (1998, XXVIII, section 243 ⁄ 1998, 
renewed in 22.1/360/3/2011), and with the guidelines of the institutional ethical code. 
Interneurons for electrophysiological recordings were sampled in slices prepared from wild 
type mice (CD1 or C57Bl/6J strains) or from transgenic mice expressing enhanced green 
fluorescent protein (eGFP) controlled by the glutamate-decarboxylase 65 promoter (GAD65, 
(Lopez-Bendito et al., 2004)). Some interneurons for morphological studies were 
intracellularly labeled in slices prepared from mice expressing red fluorescent protein 
(DsRed) under the control of the cholecystokinin promoter (BAC-CCK-DsRED, (Mate et al., 
2013)). Mice of both sexes (postnatal day 15–23) were deeply anaesthetized with isoflurane 
and decapitated. The brain was quickly removed and placed into ice-cold cutting solution 
containing (in mM): 205 sucrose, 2.5 KCl, 1.25 NaH2PO4, 5 MgCl2, 0.5 CaCl2, 26 NaHCO3, 
and 10 glucose. The cutting solution was bubbled with 95% O2 /5% CO2 (carbogen gas) for at 
least half an hour before use. Horizontal hippocampal slices (300 µm thick) were prepared 
using a Leica VT 1000S or a VT1200S microtome (Leica, Nussloch, Germany), and kept in 
an interface-type holding chamber at room temperature for at least 60 min before recording in 
standard ACSF with the composition of (in mM) 126 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2 
MgCl2, 2 CaCl2, 26 NaHCO3, and 10 glucose. Solutions were prepared with ultrapure water 
and bubbled with carbogen gas.  
 
CB1 content of GABAergic boutons. To reveal the ratio of GABAergic boutons expressing 
CB1, some slices prepared for electrophysiological recordings from wild type mice were 
immediately fixed overnight in 4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH 
7.4). After fixation, slices were washed with 0.1 M PB several times, embedded in 1% agar, 
and re-sectioned to 40 μm thickness. The sections were then blocked in 10% Normal Donkey 
Serum (NDS,Vector Laboratories, Burlingame, CA) made up in Tris-buffered saline (TBS, 
pH 7.4) followed by incubation in a mixture of primary antisera of rabbit anti-CB1 (1:1000, 
Cayman Chemical Company, Ann Arbor, MI), goat anti-GAD65/67 (1:1000, Frontier 
Institute Co. Ltd., Sapporo, Japan), and guinea pig anti-VGAT (1:1000, Frontier Institute Co. 
Ltd., Sapporo, Japan) diluted in Tris-Buffered Saline (TBS) containing 1% NDS and 0.1% 
Triton X-100 for three days at 4ºC. Following several washes in TBS, the sections were 
incubated in a mixture of secondary antisera of Alexa 594-conjugated donkey anti-rabbit 
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(1:500, Invitrogen, Carlsbad, CA), Alexa 488-conjugated donkey anti-goat (1:500, 
Invitrogen), and Alexa 647-conjugated donkey anti-guinea pig (1:500, Invitrogen) diluted in 
TBS for 2 hours to visualize the CB1-expressing boutons in red, the GABAergic axon endings 
in green and in far-red, respectively. Following several washes in TBS, sections were 
mounted on glass slides in Vectashield (Vector Laboratories). Coverslips were sealed in nail 
polish. Images were taken using an AxioImager Z1 microscope (Zeiss, Germany) with 40x 
objective (NA=0.75), or an A1R confocal laser scanning microscope (Nikon Europe, 
Amsterdam, The Netherlands) using a 60× (NA = 1.4) objective.  
For quantitative analysis, high magnification (60 nm/pixel) z-stack images were taken 
at 60x magnification from the upper 3 µm of the slices (z-step was 130 nm) using a Nikon 
A1R microscope. To improve the quality of the images, deconvolution was carried out with 
the Huygens Professional program (Hilversum, The Netherlands). For counting the 
colocalization of CB1, GAD65/67 and VGAT staining, one stack from the upper 1 µm was 
chosen, where the antibodies penetrated properly. From a 61.44 µm2 area chosen randomly, 
the putative immunopositive boutons were marked in one of the labelings with the NIS-
Elements Software (Nikon), and their positivity was investigated on the same image for the 
other two stainings. When the overlap of the three antibody staining could not be 
unequivocally determined in the boutons based on the confocal stack used for the evaluation 
of the colocalization, the neighboring stacks were used to inspect the colocalization. 
 
Electrophysiological recordings. Slices were transferred to a submerged type recording 
chamber. The flow rate was 2-3 ml/min. Experiments were performed at room temperature 
under visual guidance using an Olympus microscope (BX61WI, Olympus Corp., Tokyo, 
Japan). Fluorescence of eGFP- and DsRed-containing cells was excited by a monochromator 
at 488 nm and at 550 nm wavelength, respectively, and the resulting fluorescence was 
visualized with a CCD camera (TILL photonics, Gräfelfing, Germany). Whole-cell patch-
clamp recordings were made using a Multiclamp 700B amplifier (Molecular Devices), filtered 
at 2 kHz, digitized at 5 kHz with a PCI-6024E board (National Instruments, Austin, TX), 
recorded with an in-house data acquisition and stimulus software (Stimulog, courtesy of Prof. 
Zoltán Nusser, Institute of Experimental Medicine, Hungarian Academy of Sciences). Patch 
pipettes were pulled from borosilicate glass capillaries with inner filaments to have a 
resistance of 3-6 MΩ (1.5 mm O.D.; 1.12 mm I.D., Hilgenberg GmbH, Malsfeld, Germany). 
To obtain recordings from CB1-expressing interneurons in CA3, cells were selected by the 
eGFP content (in slices prepared from GAD65-eGFP mice), by the DsRed expression (in 
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slices prepared from BAC-CCK-DsRed mice), or by the soma size and by on-line 
investigation of their firing characteristics using gradually increasing hyper- and depolarizing 
current steps (in slices prepared from wild type mice). The CB1 immunostaining in the CA3 
region of the hippocampus was similar between wild-type mice and mice from both 
transgenic lines (Supplementary figure 1).  Due to this, we combined the analysis of CB1-
expressing interneuron properties across all strains. Additionally, all cells measured in slices 
originating from wild type mice were tested for CB1 positivity post hoc with immunostaining. 
Data from two cells that could not be identified successfully as CB1-expressing were not 
included in this study. In slices prepared from GAD65-eGFP mice, we preferentially selected 
eGFP-positive cells possessing large somata that corresponded to the interneurons expressing 
CB1 (Figure 2; (Wierenga et al., 2010)). The intrapipette solution used for the interneurons 
contained (in mM) 110 K-gluconate, 4 NaCl, 2 Mg-ATP, 40 HEPES, 0.3 GTP, 0.2% biocytin, 
adjusted to pH 7.3 using KOH, osmolarity was 290 mOsm/l. After break-in, we tested the 
voltage responses to a series of hyperpolarizing and depolarizing square current pulses of 800 
ms duration and amplitudes between -100 and 100 pA at 10 pA step intervals, then up to 300 
pA at 50 pA step intervals and finally up to 600 pA at 100 pA step intervals from a holding 
potential of -65 mV in each cell. Using these voltage responses, we characterized any active 
and passive membrane properties of CB1-expressing interneurons with an in-house analysis 
software SPIN 1.0.1 (courtesy of Prof. Zoltán Nusser), and a custom-made program written in 
MATLAB (for details, see Tables 1 and 2 and (Antal et al., 2006; Papp et al., 2013). 
Rheobase was defined as the minimum current step at which the cell fired at least 3 action 
potentials. The maximal current step was the highest current injection generating firing 
without distortion. The decay time constant of IPSCs was obtained by fitting a single 
exponential decay to the descending phase of synaptic events. Using slice preparations, single 
cell properties were examined in 38 interneurons from wild-type and 35 interneurons from 
GAD65-eGFP mice. There were no significant differences (p>0.1) in these properties 
between groups, therefore these results from both mouse lines were pooled.   
In paired recordings, the presynaptic cell was a CB1-expressing interneuron and the 
postsynaptic cell was a pyramidal cell. The intrapipette solution used for the postsynaptic cell 
contained (in mM) 80 CsCl, 60 Cs-gluconate, 1 MgCl2, 2 Mg-ATP, 3 NaCl, 10 HEPES, and 5 
QX-314 (2(triethylamino)- N-(2,6-dimethylphenyl) acetamine), adjusted to pH 7.3 with 
CsOH, and the osmolarity was 295 mOsm/l. Presynaptic interneurons were held in current 
clamp mode at a membrane potential of -65 mV, and stimulated by brief current pulses (1.5 
ms, 1-2 nA) to evoke action potentials. Pyramidal cells were clamped at the holding potential 
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of -65 mV. Series resistance (between 5-20 M) was frequently monitored and compensated 
by 65%. Cells where the series resistance has changed more than 25% during recording were 
discarded from further analysis. To investigate the dynamics of the transmitter release and the 
magnitude of the asynchronous release, we calculated the average of unitary inhibitory 
postsynaptic current (IPSC) amplitudes in response to ten action potentials at 30 Hz evoked in 
the presynaptic cell. These trains of action potentials were evoked at 0.05 Hz during each 
recording (Figure 7).  
 
Post hoc anatomical identification of interneurons. After recording, slices were fixed 
overnight in 4% paraformaldehyde in 0.1 M PB (pH 7.4). Following fixation, slices were 
washed with 0.1 M PB several times. Biocytin-filled cells from GAD65-eGFP mice were 
visualized with Alexa 488-conjugated streptavidin (Alexa 488, 1:3000, Invitrogen), while 
filled interneurons from wild type or BAC-CCK-DsRed mice were visualized with Cy3-
conjugated streptavidin (1:1000; Sigma-Aldrich). It was possible to visualize the axons of the 
interneurons despite the fact that the conjugated fluorophore was the same color already 
expressed by the transgenic animals because the fluorophore conjugated to streptavidin 
generates a much stronger signal in axon terminals compared to the genetically encoded 
fluorescence. If axon collaterals of the recorded cells could be seen, then slices were 
embedded in 1% agar and re-sectioned to 40 μm thickness. The sections were then blocked in 
NGS (10%, Vector Laboratories) made up in TBS (pH 7.4) followed by incubation in rabbit 
anti-CB1 (Cayman Chemical Company, Ann Arbor, MI) diluted 1:1000 in TBS containing 2% 
NGS and 0.05% Triton X-100. Following several washes in TBS, CB1 expression was 
visualized using Alexa 594 (goat anti-rabbit, 1:500, Invitrogen) on GAD65-eGFP mice and 
Alexa 488 (goat anti-rabbit, 1:500, Invitrogen) in BAC-CCK-DsRed mice. In cases of both 
single and double stainings, the incubations were followed by several washes in TBS. 
Sections were mounted on slides in Vectashield (Vector Laboratories). Images were taken 
using an AxioImager Z1 microscope (Zeiss, Germany) or a Nikon A1R confocal laser 
scanning microscope using a 60× (NA = 1.4) objective. For high magnification images, single 
confocal images or maximum intensity z-projection images were used (2-3 confocal images at 
0.3-3 μm).  
Subsequently, representative interneurons were further developed by 
immunoperoxidase reaction using Nickel-intensified Di-amino-benzidine (DAB-Ni), for 
morphological reconstruction. Briefly, biocytin was visualized using avidin-biotinylated 
horseradish peroxidase complex reaction (ABC; Vector Laboratories) with DAB-Ni as a 
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chromogen. After dehydration and embedding in Durcupan (Fluka), neurons were 
reconstructed with the aid of a drawing tube using a 40x objective. To determine the 
proportion of the labeled interneuron axons in various layers of the hippocampus, we scanned 
in drawings of axon arbors into Adobe Photoshop and quantified the pixels representing 
axons, normalized to the background. Coefficient of variation (CV, the standard deviation 
divided by the mean) of axonal distribution was calculated from the proportion of the axon 
collaterals in the principal layer for each cell in a given group.  
 
Statistical analysis. In those cases, where the Shapiro-Wilk and Kolmogorov-Smirnov tests 
rejected the hypothesis that the data were taken from normal distributions, a non-parametric 
Kruskal-Wallis (KW) ANOVA or Mann-Whitney (MW) test was performed and data are 
presented as median and interquartile range. Otherwise, ANOVA, paired or two sample t-test 
was used and the results are given as mean±SEM. Pearson’s chi-square tests with Bonferroni 
correction were used for comparison of the CB1-expressing bouton ratios among different 
layers. STATISTICA 11 software (Statsoft, Inc., Tulsa, OK) or Origin 8.6 software 
(Northampton, MA) was used for statistical evaluations of differences.  
  
 
RESULTS 
 
A large population of GABAergic boutons expresses CB1 in the CA3 region of the 
hippocampus 
 
In order to reveal the proportion of GABAergic axon endings expressing CB1, we visualized 
inhibitory boutons with an antibody developed against both isoforms of the GABA 
synthesizing enzyme GAD (GAD65 and GAD67) or in a separate set of experiments, with an 
antibody developed against the vesicular GABA transporter, VGAT and co-stained the 
sections in both cases with an antibody that recognizes CB1. In the stratum pyramidale, where 
most axon terminals are inhibitory (Megias et al., 2001; Kaneko et al., 2002), we found that 
70% of CB1-positive axon terminals (273 out of 391 boutons from three animals) were also 
positive for GAD65/67 and, similarly, 78% of CB1-expressing axon terminals (307 out of 391 
boutons from three animals) were immunoreactive for VGAT. This incomplete co-
localization of these two proteins defining the GABAergic phenotype of axon terminals with 
CB1 was unexpected, because the antibody used to visualize CB1 in this study labels only 
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inhibitory, but not excitatory boutons (Hajos et al., 2000). Therefore, we next tested the co-
localization of GAD65/67 and VGAT in the boutons located in the stratum pyramidale, 
although a previous study showed that VGAT and GAD65/67 could be present even at the 
same synaptic vesicles (Jin et al., 2003) and should thus label the same set of GABAergic 
terminals. In contrast to this obvious prediction, we observed that there was a large, but not 
complete overlap between these two markers for GABAergic phenotype under our conditions 
(88% of VGAT-immunolabeled boutons (389 from 440 boutons) showed GAD65/67 
immunoreactivity; 87% of GAD65/67-immunoreactive boutons (349 from 403 boutons) were 
VGAT immunopositive, tested in the stratum pyramidale in three animals). Therefore, we 
chose to label inhibitory terminals by a mixture of antibodies developed against VGAT and 
GAD65/67 to maximize the number of visualized GABAergic boutons.  
Under our conditions, confirming our previous data (Hajos et al., 2000), the anti-CB1 
antibody labeled mainly, if not exclusively GABAergic terminals, because the vast majority 
of CB1-immunpositive boutons was found to be immunoreactive for GAD65/67 and/or 
VGAT in all layers of CA3 (81% of CB1-immunoreactive boutons (277 out of 341) in the 
stratum oriens; 86% (336 out of 391) in the stratum pyramidale; 90% (383 out of 427) in the 
stratum lucidum; 94% (290 out of 307) in the stratum radiatum; 91% (349 out of 384) in the 
stratum lacunosum-moleculare were immunopositive for GAD65/67 or VGAT, calculated 
from three animals). Conversely, we found that approximately 40% of all inhibitory axon 
terminals labeled for GAD65/67/VGAT were immunopositive for CB1 irrespective of the 
layer in CA3 (Figure 1, Table 1). The only exception was the stratum pyramidale, in which 
layer the percentage of CB1-expressing GABAergic boutons was 50%, a proportion that was 
significantly higher compared to that found in strata lucidum, radiatum and lacunosum-
moleculare, but not in stratum oriens (P<0.01, Pearson’s chi-square test). This surprisingly 
high ratio of CB1-expressing GABAergic varicosities indicates that CB1 can control the 
GABA release in a significant proportion of inhibitory axon endings in CA3. 
 
Morphology of interneurons expressing CB1 in CA3 
 
In the next set of experiments, we aimed to determine the origin of the CB1-expressing 
boutons in CA3. To uncover the interneuron types giving rise to this dense meshwork of axon 
endings immunoreactive for CB1 in all layers of CA3, we intracellularly-labeled interneurons 
in hippocampal slices. CB1-expressing interneurons were identified by immunolabeling for 
CB1 in case of cells sampled in slices prepared from wild type mice (n=90), GAD65-EGFP 
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transgenic mice (n=40) or BAC-CCK-DsRed mice (n=5). In slices prepared from GAD65-
EGFP transgenic mice green cells with large soma were preferentially targeted, which 
interneurons express CB1 (n=40; Figure 2, (Wierenga et al., 2010)). After morphological 
identification, a total of 135 identified interneurons were included in the study.  
Based on their axonal projection, CB1-expressing interneurons in CA3 could be 
divided into four main groups (Figure 3). Axon collaterals of basket cells (BC, n=38) were 
mostly present in the pyramidal cell layer and its vicinity (Figure 4A). Mossy-fiber-associated 
cells (MFA cell, n=32) had their axon clouds mainly in the stratum lucidum, and gave rise to 
some additional collaterals in the hilus. Axon arbors of dendritic-layer-innervating cells (DLI 
cell, n=52) were observed prevalently in the stratum radiatum, but their axon branches could 
be occasionally traced into the stratum moleculare of the dentate gyrus. Perforant-path-
associated cells (PPA cell, n=11) projected their axons almost exclusively into the stratum 
lacunosum-moleculare. Overall, these interneurons with different axon arborization patterns 
had comparable multipolar dendritic trees, covering several layers of the CA3. Although there 
was some correspondence between the location of the cell bodies of different types of CB1-
expressing interneurons and their main axonal projection, a considerable overlap between the 
soma locations of distinct interneuron types could be noticed. In general, BCs were sampled 
mainly within or near the stratum pyramidale, MFA cells in the stratum lucidum, DLI cells in 
the middle part of the stratum radiatum, while PPA cells were most often found at the border 
of strata radiatum and lacunosum-moleculare. However, in each cell category, cell bodies 
could be often found outside of the ‘principal’ location listed above, where the majority of the 
somata of a given cell type was identified (Figure 4). In addition to the variability in the soma 
location of CB1-expressing interneuron types, there was a substantial diversity in axonal 
arbors within each class of cells (Figure 4). We often observed smaller or larger deviations 
from the ‘prototypical’ examples (Figure 3). To compare quantitatively the axon arbors of 
distinct cell types filled in slice preparations, we measured the axon length in distinct layers. 
While the stratum pyramidale and stratum radiatum was divided into two and three equal bins, 
respectively, all other layers in CA3 and in the dentate gyrus were represented as a single bin 
(Figure 4). Although BCs could have wide axon clouds penetrating deeply even into strata 
radiatum or oriens, or, in contrast, could display a narrow axon tree at the border of strata 
pyramidale and oriens (Figure 4A), on average the majority of the axon cloud was restricted 
to the stratum pyramidale (70.2±17.2 %, CV (coefficient of variation) =0.24 , n=8). While the 
axon arbors of MFA cells were mainly present to the stratum lucidum (43.9±14.01%, 
CV=0.32, n=9), their axon collaterals often innervated the closest part of the stratum 
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pyramidale (15.05±7.9%) and of the stratum radiatum (20.3±11.5%). In 15 out of 32 MFA 
cells, their axons were found to penetrate into the hilus. The most diverse axon clouds were 
observed in case of DLI cells. Although, on average, the axon cloud of DLI cells was mainly 
found in the stratum radiatum (79.6±22.3%, CV=0.28, n=6), their collaterals were observed in 
the stratum oriens, and occasionally also penetrated into the stratum lacunosum-moleculare. 
In contrast to this ‘wide’ axonal appearance, we also observed DLI cells with narrow axonal 
arborization within the stratum radiatum (Figure 4C). In 20 out of 52 DLI cells, axon 
collaterals were observed in the stratum moleculare of the dentate gyrus. The least variance in 
axon projection was noticed among PPA cells. In most of the cases, their axons were 
restricted to the stratum lacunosum-moleculare (83.3±8.8%, CV=0.11; n=5), but we found 
examples where axon collaterals of PPA cells left the stratum lacunosum-moleculare and 
formed a meshwork in the stratum radiatum close to the border of the stratum lacunosum-
moleculare (Figure 4D). In addition to these previously identified cell types (Lasztoczi et al., 
2011), we found two interneurons with their axon clouds predominantly, albeit not 
exclusively located in the stratum oriens (82.4% and 37.1% of the total axon, respectively, 
Figure 4E). A part of their axon collaterals penetrated into the strata pyramidale and lucidum.  
In summary, four main types of CB1-expressing interneurons were identified in CA3 
with rather similar dendritic morphology, but we observed a large morphological diversity in 
their axonal projections, even among cells within each of these categories. Furthermore, two 
interneurons were identified, which had axon arbors mainly in the stratum oriens.   
 
Membrane properties of CB1-expressing interneurons 
 
Next, we asked whether the differences in axon arborization also manifest as individual cell 
features. To address this question, we investigated the active and passive membrane 
properties of CB1-expressing interneurons in slices prepared from wild type mice or from 
GAD65-EGFP transgenic mice. To this end, we injected gradually-increasing depolarizing 
and hyperpolarizing current steps into the interneurons using the whole-cell patch-clamp 
technique, and analyzed their voltage responses. We found that the majority of the examined 
parameters (9 out of 15) were similar in the four anatomically-distinguished cell types (Table 
2). However, we found some significant differences, e.g. action potential threshold, the 
adaptation of action potential amplitude, and relative sag amplitude differed between groups 
(Table 2). It is interesting to note that, although the membrane capacitance between cell types 
differed (Table 2), their membrane time constants were similar, offset by input resistance 
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(Table 2). To compare the firing capability of distinct cell types, we plotted the firing 
frequency as a function of the intracellularly-injected current step amplitudes (Figure 5A). We 
observed that all types of CB1-expressing interneurons responded to a given current input with 
similar spiking frequencies (Figure 5B). 
 These data show that in contrast to the large morphological variance in axon arbors of 
CB1-expressing interneurons, most of their single-cell properties and firing characteristics are 
similar.  
 
Features of CB1-expressing interneuron output synapses 
 
The possible differences in synaptic inhibition along the somato-dendritic axis of pyramidal 
cells can substantially impact the signal processing. Therefore, in addition to membrane 
properties, we aimed to compare various features of synaptic transmission at the synaptic 
outputs of CB1-expressing interneurons. To this end, we performed paired recordings between 
CB1-expressing interneurons and their pyramidal cell partners in the CA3 region of 
hippocampal slices. The probability of finding a monosynaptically coupled pair was 83% (51 
pairs out of 61 trials). Due to the lack of detectable postsynaptic response in all but one dual 
recording from PPA cell and pyramidal cell pairs (peak amplitude, 38.5 pA; potency, 34.4 
pA; 10-90% rise time, 7.66 ms, decay time constant, 14.3 ms; probability of failures, 0.1; 
latency, 2.85 ms, charge of asynchronous release, 899 pA*ms, the ratio of the 10
th
 and the 1
st
 
uIPSC amplitude, 1.15), we focused our study on the synaptic properties of connections 
originating from BCs (n=20), MFA cells (n=14) and DLI cells (n=21). Unitary inhibitory 
postsynaptic currents (uIPSCs) in pyramidal cells were evoked by single action potentials in 
the presynaptic interneurons. We compared the peak amplitude (including failures), potency 
(excluding failures), 10-90% rise time and decay time constant. Additionally, the synaptic 
latency of transmission (i.e. the time between the peak of action potentials and the beginning 
of the uIPSC) as well as the probability of transmission failures were calculated (Figure 6, 
Table 3). Statistical comparison of these data revealed that the peak amplitude of the uIPSC 
(P<0.001, KW ANOVA), the synaptic potency (KW ANOVA; P<0.001), the 10-90% rise 
time (P=0.002, KW ANOVA), and the decay time constant (P=0.009, KW ANOVA) were 
different. Post-hoc statistical investigations showed that DLI cells differ significantly from the 
other two groups in their synaptic potency, 10-90% rise time and decay time constant, while 
the uIPSC amplitude was found to be different only between BC-pyramidal cell and DLI cell-
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pyramidal cell pairs (Table 3). No difference could be detected in failure rate (P=0.56, KW 
ANOVA) or latency (P=0.82, KW ANOVA; Figure 6B, Table 3) among the three groups.  
These results show that the properties of output synapses of BCs and MFA cells are 
similar, while the differences observed at synaptic contacts between DLI cells and pyramidal 
cells may be explained by the dendritic location of the synapses, because dendritic filtering 
could substantially affect the amplitude and rise time of uIPSCs recorded at the soma 
(Spruston et al., 1993).  
 
Comparison of short-term plasticity and the magnitude of asynchronous release at the 
synapses of CB1-expressing interneurons  
 
In our previous study, we found that the output synapses of BCs show little, if any, 
short-term changes in the uIPSC amplitude evoked by a train of action potentials on average 
(Szabó et al., 2010). Here, we extended this investigation by testing the synaptic dynamics in 
other types of CB1-expressing interneurons contacting pyramidal cells. Consistent with our 
previous results, we found that in BC-pyramidal cell pairs, the short-term plasticity evaluated 
by trains of ten action potentials evoked at 30 Hz was variable, observing depressing, 
facilitating or facilitating-depressing patterns, but on average there was no substantial change 
in the uIPSC amplitude during the train (median: 0.78, interquartile range: 0.65-1.49, n=19; 
Figure 7A-C). Synapses in DLI cell-pyramidal cell pairs behaved similarly (median: 0.85, 
interquartile range: 0.66-1.08, n=24; Figure 7A-C). In contrast, facilitation or facilitation-
depression characterized the synapses in most of the MFA cell-pyramidal cell pairs on 
average (median: 1.11, interquartile range: 0.59-1.40, n=14; Figure 7A-C). At the population 
level, the short-term plasticity depicted by the ratio of the 10
th
 and the 1
st
 uIPSC amplitude 
during the train was distinct at synapses in MFA cell-pyramidal cell pairs compared to that 
observed in DLI cell-pyramidal cell pairs (P<0.05, MW test, Figure 7C). Next, we asked the 
question whether the differences in short-term dynamics in IPSC amplitude during a train of 
action potentials (Figure 7) might be explained by the variations in tonic activation of CB1 at 
axon terminals (Losonczy et al., 2004). We specifically examined the BC- and MFA-
pyramidal cell connections and compared the IPSC amplitudes recorded in these cell pairs 
before and after the bath-application of AM251. The rationale behind the comparison of the 
AM251 effect only for the output synapses of BCs and MFA cells was that the axonal 
arborizations of these GABAergic cells preferentially occupy the perisomatic region of CA3 
pyramidal cells, thus, neither the electrical filtering of signals (Figure 6), nor the spatial 
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difference in the axon arbors (Figure 4) would substantially affect the results. The analysis 
revealed that the AM251 treatment similarly increased the IPSC amplitude evoked by single 
action potentials recorded in BC- and MFA-pyramidal cell pairs (141.9±28.8% of control, 
n=7, and 240.1±98.9% of control, n=4, respectively, P=0.258). In these experiments, AM251 
wash-in caused a significant increase in IPSC amplitude in two BC- and two MFA-pyramidal 
cells pairs (P<0.05, paired t-test), but not in other pairs. At population level, this CB1 
antagonist under these recording conditions did not alter the IPSC amplitudes significantly in 
either groups (P=0.25 for BC, n=7; P=0.28 for MFA, n=4, paired t-test). As in the previous 
set of experiments (Figure 6, Table 3), the amplitude of IPSCs recorded during control period 
was comparable in BC-pyramidal cell pairs (248.1±51.5 pA, n=7) and in MFA-pyramidal cell 
pairs (260.7±97.1 pA, n=4; P=0.9, two sample t-test). These results suggest that the tonically 
active CB1  receptors at axon terminals of interneurons that innervate the perisomatic region 
of CA3 pyramidal cells similarly impact the basal synaptic transmission, and thus these 
receptors may not be primarily responsible for the difference in short-term plasticity under our 
recording conditions. In summary, these data indicate that BCs and DLI cells provide a 
constant synaptic inhibition along the somato-dendritic axis of CA3 pyramidal cells for a 
period of time when activated synchronously, while MFA cells can dynamically change their 
inhibitory control in the mossy fiber termination zone if the spiking of MFA cells evolves 
during network activities.  
 Earlier works (Hefft and Jonas, 2005; Daw et al., 2009; Szabo et al., 2010) have 
described how a train of action potentials can be followed by a sustained and significant 
release of GABA from axon endings expressing CB1, but this feature is less pronounced at 
boutons containing a Ca
2+
 binding protein parvalbumin. This prolonged synaptic inhibition 
followed by a spike train was named asynchronous release, which was proposed to be the 
result of the build-up of the intra-boutonal Ca
2+
 concentration during the spike trains that lasts 
for tens of milliseconds. Since we found earlier that a train of ten action potentials evoked at 
30 Hz is very effective in inducing asynchronous release at synapses of CB1-expressing BCs, 
we tested the ability of the output synapses of MFA and DLI cells to produce a prolonged 
post-train inhibition using the same protocol. We found that asynchronous release of GABA 
could be detected in all the tested types of CB1-expressing interneuron-pyramidal cell pairs, 
but the magnitude of this prolonged inhibition was different for each interneuron type (charge 
in pA*ms: BC; median: 974.1, interquartile range: 712.2-2589.4, n=19; MFA; median: 
2171.1, interquartile range: 691-6679.2, n=14; DLI; median: 823.7, interquartile range: 488.6-
2088.1, n=24; Figure 7A, D). By comparing the IPSC charge before and after the action 
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potential trains, larger sustained inhibition was observed at synapses formed by MFA cells 
than by DLI cells (P<0.05, MW test; Figure 7D). These results show that MFA cells have the 
ability to impact the function of their main postsynaptic partners, the CA3 pyramidal cells, for 
longer period of time than BCs or DLI cells.  
 
CB1 activation at the output synapses of interneurons projecting onto distinct domains 
of CA3 pyramidal cells similarly decreases the IPSC amplitude 
 
In order to confirm that CB1 cannabinoid receptors detected immunocytochemically at the 
output synapses of investigated interneuron types are indeed functional, we tested the 
endocannabinoid sensitivity of these connections. The endocannabinoid release from the 
postsynaptic pyramidal cells was achieved by activating M1/3 muscarinic receptors. As it was 
previously shown, the activation of these cholinergic receptors triggers release of retrograde 
signaling molecules from pyramidal cells in a Ca
2+
 dependent manner, resulting in the 
reduction of the IPSC amplitude, which reduction could be prevented by blocking CB1 
function (Fukudome et al., 2004; Makara et al., 2007; Neu et al., 2007). Using this well-
established protocol to activate CB1 at inhibitory synapses, we applied 5 µM carbachol (CCh), 
a cholinergic receptor agonist during paired recordings and evaluated the CCh effects at 
individual synaptic connections. In these experiments the average amplitude of postsynaptic 
responses evoked by 10 action potentials at 30 Hz was obtained (i.e. we measured the 
amplitude of 10 individual IPSCs evoked by a train and calculated their average) and 
compared before and during the drug treatment. We observed that CCh application invariantly 
reduced the averaged IPSC amplitude in all the connections tested (n=16). In BC-pyramidal 
cell pairs, the IPSC amplitudes were significantly reduced to 15.0±10.9% of control upon 
CCh treatment (control, 130.7±31.1 pA; in CCh, 12.5±8.5 pA, n=6, P=0.01, paired t-test). In 
MFA-pyramidal cell pairs, CCh suppressed the IPSC amplitude to 3.2±1.1 % of control 
(control, 156.4±63.2 pA; in CCh, 3.2±0.8 pA, n=4, P=0.045, paired t-test). In DLI-pyramidal 
cell pairs, the amplitudes of IPSCs decreased to 23.1±6.3% of control in the presence of CCh 
(control, 36.9±3.6 pA; in CCh, 7.7±1.7 pA, n=6, P <0.001, paired t-test)(Figure 8A-C, G). 
The efficacy of the depression caused by CCh did not differ among pairs grouped by 
interneuron type (P=0.31, ANOVA, Figure 8G).  
Next, we tested whether the reduction in IPSC amplitudes upon CCh treatment was 
mediated via CB1 receptor activation. To this end, the effects of CCh on IPSC amplitude were 
evaluated in 2 µM AM251 applied for 30-40 min before the CCh treatment. In all three types 
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of interneuron-pyramidal cell pairs, the pre-treatment of slices with AM251 prevented the 
significant suppression of IPSC amplitudes upon CCh application, indicating that this 
cholinergic agonist reduced the inhibitory synaptic transmission indeed via CB1 activation 
(BC-pyramidal cell pairs, in AM251, 181.8±31.7 pA, in AM251+CCh, 147.4±29.4 pA, n=6, 
P=0.1; MFA-pyramidal cell pairs, in AM251, 111.2±27.7 pA, in AM251+CCh, 74.3±11.3 
pA, n=3, P=0.11; DLI-pyramidal cell pairs, in AM251, 38.6±8.0 pA, in AM251+CCh, 
33.9±7.0 pA, n=6, P=0.09, paired t-test, Figure 8D-G).  
In the last part of these experiments, we aimed to clarify whether M1/3 muscarinic 
receptors were involved in CCh-induced suppression of inhibitory transmission, similarly to 
that observed in other brain regions (Fukudome et al., 2004; Makara et al., 2007; Neu et al., 
2007). Indeed, the pre-treatment of slices in a M1/3 muscarinic receptor antagonist (10 µM 
pirenzepine) blocked the effect of CCh at inhibitory synapses, because no significant 
reduction in IPSC amplitude could be detected in paired recordings (BC-pyramidal cell pairs, 
in Pir, 98.8±30.8 pA, in Pir+CCh, 79.6±20.8 pA, n=5, P=0.17; MFA-pyramidal cell pairs, in 
Pir, 95.2±32.8 pA, in Pir+CCh, 79.5±25.7 pA, n=3, P=0.35; DLI-pyramidal cell pairs, in Pir, 
35.2±9.6 pA, in Pir+CCh, 26.4±6.9 pA, n=5, P=0.07, paired t-test, Figure 8G).  
Our data collectively suggests that the activation of M1/3 muscarinic receptors leads to 
endocannabinoid production and these signaling molecules can effectively suppress synaptic 
transmission at the output synapses of CB1-expressing interneurons in the CA3 region.  
 
 
Discussion  
 
One of the main findings of our study is that approximately 40% of GABAergic 
boutons in each layer of CA3 were found to be immunoreactive for CB1. However, we cannot 
rule out the possibility that a small proportion of GABAergic boutons were not labeled, even 
when using antibodies recognizing the two key proteins of the inhibitory phenotype. The large 
proportion of inhibitory boutons expressing CB1 seems to be surprising in the light of 
previous immunocytochemical findings, where the ratio of distinct classes of GABAergic 
cells was estimated by counting the immunoreactive cell bodies. These estimates proposed 
that CB1/CCK-expressing GABAergic cells form approximately 10-15 % of all GABAergic 
cells in the hippocampus (Kosaka et al., 1985; Jinno and Kosaka, 2006). The apparent 
discrepancy between our study and previous estimations strengthens the idea that distinct 
types of inhibitory cells could give rise to a substantially different number of varicosities (for 
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review see (Bezaire and Soltesz, 2013). An alternative explanation, which does not rule out 
the previous scenario, might be that the detection of CCK or CB1 levels at some somata can 
be below the threshold of the immunostaining, whereas at axon endings CB1 can be readily 
visualized. This latter possibility is in accordance with the in situ data, showing that mRNA of 
CB1 could be detected in approximately 40% of GABAergic cell bodies in the hippocampus 
(Marsicano and Lutz, 1999). In summary, our results suggest that in the CA3, a significant 
proportion of GABAergic boutons expresses CB1, making it possible to control GABA 
release by endogenous and exogenous agonists of CB1 at a substantial fraction of inhibitory 
axon endings. 
 The second important observation of this study is that under our recording conditions 
the large morphological variability of CB1-expressing interneurons is accompanied by similar 
electrophysiological properties regarding both the single-cell characteristics and the features 
of synaptic transmission. The morphological diversity of axon arbors of both CB1/CCK-
expressing basket cells and dendritic-layer-innervating cells has already been acknowledged 
(Cope et al., 2002; Klausberger et al., 2005; Lasztoczi et al., 2011; Tricoire et al., 2011). In 
contrast to the large anatomical variability, the single-cell properties of distinct morphological 
types of CB1/CCK-expressing interneurons in CA3 were found to be rather similar, except 
some features where we revealed significant differences, similarly to that found in CA1 (Cea-
del Rio et al., 2011). One of the differences was the slower decaying phase of IPSCs at the 
output synapses of DLI cells in comparison with BCs or MFA cells. The reason for this could 
be two-fold. First, dendritic filtering might play a substantial role in shaping the IPSC kinetics 
recorded at the soma (Spruston et al., 1993; Maccaferri et al., 2000). Second, the subunit 
composition of GABAA receptors at the output synapses of CB1-expressing interneurons 
targeting the distinct surface of pyramidal cells could also be distinct, potentially contributing 
to the slower IPSCs with dendritic origin (Pearce, 1993; Nyiri et al., 2001). Overall, both the 
similarities and differences in the investigated properties were comparable to that found in the 
case of CB1/CCK-expressing interneurons recorded in CA1 (Cope et al., 2002; Lee et al., 
2010; Cea-del Rio et al., 2011; Iball and Ali, 2011) or in the neocortex (Galarreta et al., 2008; 
De-May and Ali, 2013). Similarly to the previous studies obtained in CA1 (Daw et al., 2009; 
Lee et al., 2010), we observed that uIPSCs evoked by BCs or MFA cells were faster and 
larger than those evoked by DLI cells, as may be expected from the differences in synaptic 
location along the somato-dendritic axis of postsynaptic pyramidal cells. This observation 
may imply that uIPSCs originating from dendritic synapses can have comparable size and 
kinetics locally, at the site of their origin, to those events that derive from perisomatic 
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synapses. Hence, the inhibitory potency of synapses given rise to by distinct types of CB1-
expressing interneurons might be alike locally. Moreover, we found that both the short-term 
plasticity of the synapses and the ability of synapses to induce asynchronous transmitter 
release upon a train of action potentials in BC - and DLI -pyramidal cell pairs were similar, in 
agreement with such observations in CA1 (Daw et al., 2009). However, the synapses formed 
by MFA cells were different in these features, because the dynamics of uIPSCs in MFA -
pyramidal cell pairs showed facilitation-depression in general, and these GABAergic synapses 
could release more transmitter molecules asynchronously than those axon terminals derived 
from DLI cells. However, this difference in the charge following the action potential trains 
might be partially contaminated by excitatory postsynaptic currents if GABA from MFA cell 
output synapses is not taken up by transporter molecules (Booker et al., 2013), and may spill 
over to mossy terminals evoking glutamate release upon GABAA receptor activation (Ruiz et 
al., 2010). 
 In addition to interneurons with large cell bodies that express CB1 in GAD65-EGFP 
mice, small EGFP-expressing cells were also observed. These neurons lacked CB1 expression 
at their somata and, therefore, could correspond to distinct types of hippocampal GABAergic 
cells. A recent study demonstrated that in this transgenic mouse line neuropeptide Y (NPY), 
vasoactive intestinal polypeptide (VIP) and the Ca
2+
 binding protein calretinin could be found 
in EGFP-expressing interneurons in addition to CCK in the CA1 region (Wierenga et al., 
2010). NPY-, VIP- and calretinin-containing interneurons have relatively small cell bodies 
(Gulyas et al., 1992; Acsády et al., 1996; Acsady et al., 1997), therefore, it is safe to assume 
that EGFP-positive, but CB1-immunonegative interneurons observed in CA3 belonged to 
these neurochemically diverse cell types, as in CA1.  
Perisomatic region-targeting interneurons (including BCs and MFA cells) and 
dendrite-targeting interneurons (including DLI cells and PPA cells) may fulfill distinct 
functions in neuronal computation (Miles et al., 1996), and therefore coordinating their 
activity should be important during different network states (Lovett-Barron et al., 2012). CB1-
expressing interneurons projecting to the perisomatic region or dendritic layers of pyramidal 
cells were found to have largely similar electrophysiological properties, therefore the question 
arises whether their activity can be coordinated by the same extra- or intra-hippocampal 
afferents. To achieve simultaneous activity of all CB1/CCK-expressing interneurons, which 
would then provide a uniform inhibitory input along the complete somato-dendritic axis of 
CA3 pyramidal cells, a common input should excite them. Indeed, afferents from the median 
raphe nucleus could powerfully drive the firing of the interneurons expressing CCK or 
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calbindin (a calcium-binding protein that is often present in CB1/CCK-expressing cells 
innervating the dendrites of pyramidal cells (Freund et al., 1990; Marsicano and Lutz, 1999; 
Papp et al., 1999; Varga et al., 2009)). Furthermore, cholinergic input from the medial septum 
may also excite CB1/CCK-expressing interneuron, although on a longer time scale (Szabo et 
al., 2010; Cea-del Rio et al., 2011). Thus, at least two subcortical inputs can provide the 
necessary excitation for simultaneous firing of the interneurons innervating the distinct 
compartments of pyramidal cells. During sleep, however, when e.g. the impact of the 
subcortical afferents on circuit operation is less pronounced (Kaifosh et al., 2013), the 
inhibitory function of BCs and dendrite-innervating interneurons expressing CB1 can be 
separated. In fact, it was observed that two interneuron types immunoreactive for CB1 spiked 
at the different phases of the theta rhythm in anesthetized rats (Lasztoczi et al., 2011), 
implying that inhibition of the perisomatic and dendritic regions of pyramidal cells can 
alternate in time. The third possibility is that all CB1-expressing cells could be temporarily 
and simultaneously silenced, relieving pyramidal cells from this significant source of 
inhibition. In fact, GABAergic input from the medial septum, which synapses on CB1/CCK-
expressing interneurons in the hippocampus (Gulyás et al., 1990; Papp et al., 1999), can 
effectively inhibit the spiking of interneurons (Tóth et al., 1997; Manseau et al., 2008), 
providing the basis for removing cannabinoid-sensitive synaptic inhibition from pyramidal 
cells. In addition to extrahippocampal afferents, operation of local circuitries may also 
differentially reduce the inhibitory potency of CB1-expressing interneurons forming synapses 
with the different parts of pyramidal cells. For instance, endocannabinoids released upon 
activation of metabotropic glutamate receptors (mGlu) completely blocked GABA release 
from the axon endings of CB1-positive BCs, while synaptic transmission at synapses of 
dendrite-targeting interneurons expressing CB1 was found to be only partially reduced (Lee et 
al., 2010). This finding may imply differential control of inhibition during high network 
activities, when a large population of pyramidal cells fire synchronously and release enough 
glutamate to activate the perisynaptically-located type 1 and/or 5 mGlu (e.g. during sharp 
wave-ripple oscillations, or epileptic discharges, (Buzsáki et al., 1992; Bragin et al., 1997)). In 
this scenario, the synaptic inhibition originating from CB1-expressing perisomatic BC 
terminals can collapse, whilst dendritic inhibition may still function, helping to transmit 
information from the hippocampus into the downstream areas by allowing pyramidal cell 
spiking (Cobb et al., 1995; Chrobak and Buzsáki, 1996; Miles et al., 1996).  
In summary, the morphologically distinct types of CB1/CCK-expressing interneurons 
giving rise to a large proportion of inhibitory synapses in the CA3 region of the hippocampus 
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can inhibit the somatic and dendritic domains of pyramidal cells with similar efficacy. These 
interneurons alternate the impact of their inhibition between the distinct functional domains of 
pyramidal cells in time, or temporarily relieve pyramidal neurons from synaptic inhibition, 
depending on the network state controlled by subcortical afferents, or by intrinsic network 
operation. Thus, the profound morphological diversity accompanied by similar 
electrophysiological characteristics of CB1/CCK-expressing interneurons may support their 
different operation in hippocampal networks that are precisely controlled by network states.  
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Table 1. Percentage of GABAergic varicosities immunoreactive for CB1 in different strata in 
CA3. The results were obtained in three mice. Individual counts are indicated in each row for 
a given stratum. 
 
 
 
 
 
 
 
 
 
 
 
 
*CB1-expressing 
GABAergic boutons 
were found in 
significantly higher 
proportion in 
stratum pyramidale 
compared with 
strata lucidum, 
radiatum or 
lacunosum-
moleculare (P<0.01). 
 
Layer Number of 
GABAergic 
boutons 
Number of 
CB1 
expressing 
GABAergic 
boutons 
Percentage of 
GABAergic 
boutons 
expressing 
CB1 
Average 
percentage 
from three 
mice (%) 
str. oriens 
150 62 41 
42±5.6 150 55 37 
300 146 48 
str. 
pyramidale 
195 101 52 
50±2.6* 282 144 51 
300 142 47 
str. 
lucidum 
220 96 44 
40±3.5 266 100 38 
256 97 38 
str. 
radiatum 
200 82 41 
39.7±3.2 271 113 42 
228 83 36 
str. lac.-
moleculare 
215 73 34 
36.3±2.5 214 83 39 
250 90 36 
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Table 2. Electrophysiological properties of CB1-expressing interneurons.  
 
 BC  
(n=14) 
MFA  
(n=16) 
DLI  
(n=26) 
PPA  
(n=11) 
P values 
(KW ANOVA) 
Rheobase (pA) 175 (80-300) 100 (80-150) 150 (68-200) 150 (150-200) 0.257 
AP threshold 
(mV) 
-36.4  
(-40.2 - -33.4) 
-41.1  
(-43.6 - -37.9) 
-37.6  
(-40.8 - -32.4)  
-35.8  
(-38.3 - -33.3) 
0.036 
 
AHP amplitude 
(mV) 
10.75  
(8.58-15.6) 
14.65  
(8.95-15.53) 
12.4 
(10.23-15.63) 
13.7  
(9.4-15.8) 
0.794 
AHP 25% decay 21.9 
 (3.45-56.75) 
4.4  
(2.4-20.8) 
16.3  
(3.15-36.55) 
4.4  
(2.8-13.2) 
0.177 
AHP 50% decay 33 (11.6-83.2) 22.6 (4.7-42.9) 26.8 (5.9-58.9) 10.6 (6.3-27.8) 0.391 
AHP 75% decay 44.9 (16.9-98.7) 37.9 (9.2-61.8) 36.7 (11.3-75.9) 22.6 (13.3-42.2) 0.321 
AP half width 
(ms) 
1.2  
(1-1.4) 
1  
(1-.12) 
1.2  
(1.15-1.6) 
1.3  
(1-1.6) 
0.039 
Maximal spike 
frequency (Hz) 
40  
(31-43) 
38  
(28-45) 
31  
(26-43) 
41.3  
(30-53) 
0.323 
Accommodation 
ratio 
3.7  
(2.9-4.8) 
4.1  
(3.4-4.9) 
3.6  
(3.1-4.3) 
4.2  
(3.1-4.9) 
0.501 
Ratio of AP 
amplitude 
adaptation 
0.89  
(0.82-0.98) 
0.66  
(0.59-0.79) 
0.76  
(0.65-0.84) 
0.69  
(0.6-0.76) 
9.49*10
-4 
 
 BC 
 (n=14) 
MFA  
(n=13) 
DLI  
(n=19) 
PPA  
(n=10) 
P values 
(KW ANOVA) 
Input resistance 
(MΩ) 
130  
(71-174) 
182  
(145-207) 
191  
(150-217) 
198  
(89-244) 
0.083 
Membrane time 
constant (ms) 
17.8  
(11.6-22.8) 
19  
(16.1-21.8) 
19.3  
(16.4-22.1) 
22 ( 
15.1-25.8) 
0.382 
Membrane 
capacitance (nF) 
0.132  
(0.114-0.190) 
0.105  
(0.088-0.119) 
0.109  
(0.096-0.131) 
0.109 ( 
0.105-0.177) 
0.036 
Relative sag 
amplitude 
0.43  
(0.27-0.81) 
0.23  
(0.19-0.42) 
0.19  
(0.04-0.30) 
0.44  
(0.31-0.90) 
0.004 
Delay of sag 
minimum 
95.8  
(56.9-119.1) 
106.4  
(96-128.6) 
137.7  
(96.7-200.4) 
107.9  
(83-157.6) 
0.049 
 
Data are given as median and interquartile range in parenthesis. The results of the post hoc 
statistical comparison with Mann-Whitney test are AP threshold (mV): BC vs. MFA: 0.025, 
MFA vs. DLI: 0.021, MFA vs. PPA: 0.015; AP half width (ms): MFA vs. DLI: 0.01, MFA vs. 
PPA: 0.041; Ratio of AP amplitude adaptation: BC vs. MFA: 1.98x10
-4
, BC vs. DLI: 0.003, 
BC vs. PPA: 0.005; Membrane capacitance (nF): BC vs. MFA: 0.011, BC vs. DLI: 0.035; 
Relative sag amplitude: BC vs. MFA: 0.018, BC vs. DLI: 0.003, DLI vs. PPA: 0.018 , Delay 
of sag minimum: BC vs. DLI: 0.01 
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Table 3. Summary of unitary IPSC properties.  
 
 BC N MFA n DLI n 
Peak 
amplitude 
(pA) 
114.6  
(75.8-183.8) 
20 68.9  
(36.9-162.1) 
14 45.6  
(35.5-58.2) 
21 
Synaptic 
potency (pA) 
142.8  
(105.7-203.1) 
20 97.8  
(58.4-180.1) 
14 57.5  
(49.3-76.8) 
21 
Rise time (10-
90%, ms) 
1.49  
(0.88-2.16) 
19 1.72  
(1.08-2.85) 
14 2.84  
(2.07-4.41) 
16 
Decay time 
const. (ms) 
12.85 
(7.39-9.56) 
20 12.1 
(10.73-13.5) 
13 18.63 
(12.2-24.15) 
21 
Probability of 
failures 
0.108  
(0.037-  0.175) 
20 0.297  
(0.025-0.4) 
14 0.14  
(0.05-0.28) 
21 
Latency (ms) 2.19 (1.89-2.98) 19 2.26 (2.02-3.09) 14 2.33 (1.78-3.09) 21 
 
Data are given as median and interquartile range in parenthesis. The results of the post hoc 
statistical comparison with Mann-Whitney test are: Peak amplitude (pA): DLI vs. BC, 
p<0.001; DLI vs. MFA, p=0.07; Synaptic potency (pA): DLI vs. BC, p<0.001; DLI vs. MFA, 
p=0.015; Rise time (10-90%, ms): DLI vs. BC, p<0.001; DLI vs. MFA, p=0.018; Decay time 
constant (ms): DLI vs. BC, p=0.0102; DLI vs. MFA, p=0.011. 
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Figure legends 
 
Figure 1. Immunopositivity for CB1 can be detected in a large proportion of GABAergic axon 
terminals in the CA3 region of the hippocampus. A, Micrograph taken at low magnification of 
the staining of GABAergic terminals (shown in green) and CB1 (shown in red) in the CA3 
hippocampal region. s.o., stratum oriens; s.p., stratum pyramidale; s.l., stratum lucidum; s.r., 
stratum radiatum; s.lm., stratum lacunosum-moleculare. Yellow boxes illustrate the area and 
the localization of the higher magnification pictures shown in B-G. Scale bar, 20 µm. B, E; 
GABAergic axon endings were visualized with a mixture of antibodies raised against 
GAD65/67 (panGAD) and VGAT (for illustration, both proteins are shown in green). C, F; 
Numerous boutons are immunostained with an antibody that recognizes mostly, if not 
exclusively, CB1 present at inhibitory terminals (red). D, G; A significant fraction of 
GABAergic axon terminals are immunoreactive for CB1 (white arrows). Open arrows show 
GABAergic boutons without visible staining against CB1. Confocal images are taken from a 
single plane using a Nikon A1R microscope. Asterisks in B-D label cell bodies in the stratum 
pyramidale. Scale bars, 5 µm. 
 
Figure 2. EGFP-positive cells with a large diameter in the CA3 region of the hippocampus in 
GAD65-EGFP mice express CB1. A, B, Micrographs taken at a lower magnification from 
sections immunostained for CB1 (red). Orange arrows show the cell bodies of large 
EGFP/CB1-positive cells, while open green arrows point onto small EGFP-positive cells 
lacking CB1. Scale bars, 20 µm. s.l., stratum lucidum; s.p. stratum pyramidale. A1-3 and B1-3. 
Micrographs with a higher magnification are taken from the same cells as in A and B. 
Endogenous EGFP signal in these sections has not needed any further amplification, while 
CB1 was visualized with a secondary antibody conjugated with Alexa 594. Scale bars, 10 µm. 
Insert in A1: based on the diameter of somata (measured the shortest diameter), EGFP-
positive cells form two distinct groups. EGFP-positive cells with a soma diameter larger than 
10 µm (orange open bars) were immunoreactive for CB1, while EGFP-positive cells with 
smaller soma diameter (green bars) had no detectable immunolabeling. White bars show the 
distribution of the soma diameters of recorded and intracellularly labeled interneurons. Note 
that the distribution of soma diameter for recorded interneurons and the CB1-immunostained 
EGFP-positive cells overlaps. 
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Figure 3. Interneurons with different axonal arborization express CB1 at their axon terminals 
in CA3. Four typical CB1-expressing interneurons can be distinguished, basket cells, mossy-
fiber-associated cells, dendritic-layer-innervating cells, and perforant-path-associated cells. In 
the camera lucida reconstructions of these neuron types, the cell bodies and the dendrites are 
shown in black, while the axon collaterals are in red (scale bars, 50 µm). For each example, 
voltage responses to depolarizing (300 pA) and hyperpolarizing current steps (from -10 to -
100 pA in increments of 10 pA) are indicated (calibrations, 20 mV, 100 ms). In each case, 
CB1 expression was confirmed in their axon collaterals intracellularly labeled with biocytin 
(scale bars, 1 µm). s.lm., stratum lacunosum-moleculare; s.r., stratum radiatum; s.l., stratum 
lucidum; s.p., stratum pyramidale; s.o., stratum oriens; s.m., stratum moleculare; s.g., stratum 
granulosum; h., hilus.  
 
 
Figure 4. Large diversity of axonal projections in each type of CB1-expressing interneuron. 
Camera lucida reconstructions of interneurons from each category (dendrites, black; axon, 
red; scale bars, 50 µm). Histograms show the proportion of axon arbors in different 
hippocampal layers in each cell type. One line indicate a single cell, columns indicate the 
average of cells. Data are presented as mean ± SD. Note that the axon arbors of interneurons 
belonging to a given cell class can be restricted to a given layer, but in other cases axons 
could cover a substantially wider range, often penetrating into neighboring strata. Right, 
Distribution of cell bodies of anatomically-identified types of CB1-expressing interneurons in 
CA3. Note that there is a correspondence between the soma location and cell type, but a 
substantial overlap between the positions of cell bodies of distinct interneuron types can be 
observed. s.r., stratum radiatum; s.l., stratum lucidum; s.p., stratum pyramidale; s.o., stratum 
oriens; s.lm., stratum lacunosum-moleculare; s.m., stratum moleculare; s.g., stratum 
granulosum; h., hilus. 
 
Figure 5. The firing frequencies in the four cell types upon a given current pulse are similar. 
A, Voltage responses to depolarizing current steps (150 pA, 300 pA, 600 pA) delivered from -
65 mV. B, Average frequency-input current relationships of four interneuron types measured 
from a holding potential of – 65 mV. Data are presented as mean ± SD. BC, basket cells; 
MFA, mossy-fiber-associated cells; DLI, dendritic-layer-innervating cells; PPA, perforant-
path-associated cells.  
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Figure 6. Basic properties of inhibitory synaptic transmission in CB1-expressing interneuron-
pyramidal cell pairs. A, Examples obtained from paired recordings, where single action 
potentials were evoked in three distinct types of interneurons (top traces) and the postsynaptic 
currents were detected in CA3 pyramidal cells (bottom traces). Ten consecutive traces are 
superimposed (grey) with the average of all traces (thick grey), on which exponential fits to 
obtain the decay time constant are shown in black. B, Comparison of the peak amplitude, the 
synaptic potency, the 10-90% rise time, the failure probability, the decay time constant and 
the latency measured at synaptic contacts between CB1-expressing interneurons and 
pyramidal cells. Bars indicate medians of means (short lines) corresponding to individual cell 
pairs. Asterisks indicate significant differences. For more details see Table 3.  
 
Figure 7. Short-term plasticity and the magnitude of asynchronous release at synaptic 
contacts between CB1-expressing interneurons and pyramidal cells can be distinct. A, IPSCs 
evoked at 30 Hz show distinct dynamics depending on the presynaptic interneuron type. Ten 
consecutive traces are superimposed (grey) with the average of all traces (black). Vertical 
lines before and after the traces indicate the time intervals where the IPSC charge was 
calculated from to evaluate the magnitude of asynchronous release. Examples indicate that a 
larger IPSC charge can be measured following the IPSC train (post-train) compared to control 
(pre-train) at synapses of CB1-expressing interneurons, indicative of asynchronous 
neurotransmitter release. B, The averages of normalized peak amplitudes of IPSCs evoked by 
trains of 10 action potentials at 30 Hz show no substantial changes in short-term plasticity at 
basket and dendritic-layer-innervating cell synapses, while synaptic contacts of mossy-fiber-
associated cells display facilitation, on average. Data points on these plots are mean ± SEM. 
C, Short-term plasticity at output synapses of MFA and DLI cells is distinct. D, The IPSC 
charge after the train is larger at output synapses of MFA cells than of DLI cells. Bars indicate 
medians of means (short lines) corresponding to individual cell pairs. Asterisks indicate 
significant differences.  
 
Figure 8. Carbachol (CCh)-induced reduction in IPSC amplitude at the output synapses of 
basket cells (BC), mossy-fiber-associated (MFA) cells and dendritic-layer-innervating cells 
(DLI) is mediated via CB1. Example of paired recordings, where trains of action potentials at 
30 Hz were evoked in the presynaptic interneurons, while IPSCs were detected in the 
postsynaptic pyramidal cells under control conditions (A) and in the presence of 5 µM CCh 
(B). C, Changes in peak amplitudes in response to CCh application as a function of time. 
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Filled circles indicate the amplitude of the first IPSC in the train, open circles indicate the 
average of the amplitudes of the ten IPSCs in the train. Numbers 1 and 2 indicate the period 
where traces were taken, respectively. D, E, Representative recordings in interneuron- 
pyramidal cell pairs obtained in the presence of 2 µM AM251 (D) and after application of 5 
µM CCh (E). F, Plot of the IPSC amplitude shows no significant change following bath 
application of CCh in the presence of AM251 (filled circles, amplitude of the first IPSC in the 
train; open circles, average amplitude of the ten IPSCs in the train). G, Summary plot of the 
carbachol effect in the absence or presence of AM251 or pirenzepine. All data were 
normalized to the control values, and are represented as percentage. The numbers of pairs 
recorded under different experimental conditions are shown above the columns. Asterisks 
indicate the significant differences (p≤0.01). 
 
Supplementary figure 1. CB1 staining in the CA3 region of the hippocampus from three 
different mouse strains. Micrographs taken from sections prepared from CD1, GAD65-eGFP 
and BAC-CCK-DsRED mice demonstrate similar appearance of the CB1 staining. s.o., 
stratum oriens; s.p., stratum pyramidale; s.l., stratum lucidum; s.r., stratum radiatum; s.lm., 
stratum lacunosum-moleculare. Scale bars, 20 µm. 
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